Bob Baltera Email

Executive Chairman . Trestle Biotherapeutics

Current Roles

Employees:
7
Revenue:
$542.5k
About
Trestle Biotherapeutics, Inc. is a preclinical stage company developing bioengineered therapies for patients living with end stage renal disease. Once implanted, these bioengineered stem cell-derived tissues will get patients off dialysis, delay their need for transplantation, and one day become replacement organs.
Trestle Biotherapeutics Address
9276 Scranton Road
null, null
Trestle Biotherapeutics Email